From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
May 6, 2021
Philadelphia, PA, May 6, 2021 – IntegriChain, delivering Life Sciences’ only comprehensive data and business process platform for market access, today announced that Jen Sharpe, a Gross-to-Net (GTN) leader at the company, will present at Informa’s upcoming Bio/Pharma CFO Digital Week. Sharpe is a GTN and Life Sciences accounting expert and runs the Revenue Analytics Collaborative, a network of 800+ business and financial professionals focused on Commercial, Government, GTN, and Trade/Channel data, processes, and systems. The presentation will focus on GTN digital transformation case studies and will feature GTN leaders Tina Knell from Bridgebio and Kary Callahan from Paratek. IntegriChain is a sponsor of the virtual conference, which runs May 11-13.
“Life Sciences manufacturers recognize critical data gaps in their gross-to-net systems and processes,” said Sharpe. “Innovative teams such as those at Bridgebio and Paratek are tapping into the value of a unified data platform and automated GTN systems that deliver a single accurate, complete, and credible version of financial truth to all stakeholders, eliminating spreadsheet toil and freeing up their expertise to focus on driving the business.”
Case Study: Real World GTN Transformation using Data and Analytics | May 13 10 am
About IntegriChain’s GTN Solutions
IntegriChain offers a full suite of GTN Solutions, including:
GTN Accrual Management. An end-to-end solution for Market Access and Finance departments, pre-configured for all standard line items with robust out-of-the-box accrual methodologies, including inventory and pipeline adjustments to accruals, balance sheet reconciliation to ERP systems, and true-up functionality.
GTN Accrual Forecasting. Based on industry-standard forecast methodologies configured for each liability line item with the ability to execute multiple scenario analyses for forecasts along with functionality to compare scenarios to improve forecast accuracy, GTN modeling, and financial close efficiency.
GTN Analytics. Delivering visibility to comprehensive market access datasets that power the accuracy of GTN accruals and forecasting processes, best practices GTN reports and metrics, and visualizations of GTN trends that allow for better accrual and net-price predictability and decision-making.
GTN Advisory. IntegriChain industry experts routinely advise manufacturers on GTN readiness for launch, GTN process assessments, and GTN market analysis.
About IntegriChain IntegriChain is Life Sciences’ data and application backbone for patient access and therapy commercialization. More than 250 manufacturers rely on IntegriChain’s ICyte Platform to orchestrate commercial and government payer contracting, patient services, and distribution channels. ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine. With ICyte, Life Sciences innovators are digitalizing labor-intensive processes – freeing up their best talent to identify and resolve coverage and availability hurdles and to manage pricing and forecasting complexity. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India. For more information, visit www.integrichain.com, or follow us on Twitter @IntegriChain and LinkedIn.
Contact IntegriChain: Jennifer Guinan, Sage Strategic Marketing, 610.410.8111, Jennifer@sagestrat.com
Register Now
Webinars & Resources
See List
